REGN
Regeneron Pharmaceuticals Inc
BIOTECHNOLOGY · HEALTHCARE
Regeneron Pharmaceuticals, Inc. is a prominent American biotechnology firm headquartered in Westchester County, New York, renowned for its pioneering work in monoclonal antibodies and therapeutic proteins. The company excels in various therapeutic areas, notably oncology, ophthalmology, and immunolo...
$793.74
+1.57% (+$12.25)
Volume
586,818
52W High
$859.34
52W Low
$541.00
Market Cap
$74.48B
What to Watch This Quarter
Based on historical dataConsensus EPS
$12.89
Whisper EPS
$14.13
9.7% above consensus
Last Quarter
$12.53
Current Streak
7 Beats
Avg Surprise (4Q)
+18.21%
Next Earnings Report
Reports in 41 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q2 2026
Jul 30, 2026
1-Day:
+3.29%
5-Day:
+3.02%
Q1 2026
Apr 30, 2026
1-Day:
-0.80%
5-Day:
-0.68%
Q1 2026
Apr 29, 2026
1-Day:
+3.02%
5-Day:
+3.33%
Q4 2025
Jan 30, 2026
5-Day:
+4.53%
Revenue & Financial Performance
Revenue Whisper
$4.06B
TWN Proprietary Estimate
Last Quarter Revenue
$4.29B
+16.7% YoY
Gross Margin
86.6%
Net Margin: 30.2%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q2'26 | $4.29B | +16.7% | 86.6% | 33.1% | $1.30B |
| Q1'26 | $3.61B | +19.0% | 81.4% | 17.8% | $727.2M |
| Q4'25 | $3.88B | +2.5% | 85.0% | 22.7% | $844.6M |
| Q3'25 | $3.75B | +0.9% | 86.1% | 27.4% | $1.46B |
| Q2'25 | $3.68B | +3.6% | 85.6% | 29.4% | $1.39B |
| Q1'25 | $3.03B | -3.7% | 84.7% | 19.5% | $808.7M |
| Q4'24 | $3.79B | +10.3% | 85.1% | 26.1% | $917.7M |
| Q3'24 | $3.72B | +10.7% | 86.8% | 31.7% | $1.34B |
Company Information
Symbol
REGN
Company
Regeneron Pharmaceuticals Inc
Market Cap
$74.48B
Sector
HEALTHCARE
Next Earnings
Oct 27, 2026
Also Reporting Soon
Companies reporting earnings around the same time as REGN
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in BIOTECHNOLOGY
Compare REGN with competitors
Side-by-side earnings comparison